Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

McGill University Health Centre

A new weapon in the war against HIV-AIDS: Combined antiviral and targeted chemotherapy

Montreal, June 21, 2009 – A discovery by a team of Canadian and American researchers could provide new ways to fight HIV-AIDS. According to a new study published in Nature Medicine, HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments. This radical new therapy would make it possible to destroy both the viruses circulating in the body as well as those playing hide-and-seek in immune system cells.

The study was led by Dr. Rafick-Pierre Sekaly, of the Universite de Montreal. Dr. Jean-Pierre Routy of the Research Institute of the McGill...

• View Other Issues of Vaccine Weekly
  
• View Other NewsRx Publications